A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...

Discover how genetic fatty liver combined with diabetes and obesity significantly increases liver cancer risk, according to a ...

Metabolic diseases like obesity can increase the risk of developing liver cancer, research has shown. But how one disease predisposes to the other is unclear. In a new study, Yale researchers ...

THE rise of “manosphere” steroid use is driving a surge in liver cancer among men, experts say. Cancer Research UK reports ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several ...

National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that ...

From fast-food to ultra-processed snacks, a high-fat diet eaten over the long term may trigger biological changes in the liver that could raise the risk of cancer. Researchers from the Massachusetts ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...

Boosting levels of a naturally occurring enzyme could improve the effectiveness of the liver cancer drug sorafenib. (Image/istockphoto.com) WEST LAFAYETTE, Ind. — A breakthrough in the understanding ...